Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

IARC 50th Anniversary Conference /
Genomic interrogation of tumour samples reveals essential targets

7th - 10th Jun 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 30.06.16
Views: 1565

Dr Roland Eils - German Cancer Research Center (DKFZ), Heidelberg, Germany

Dr Eils speaks with ecancertv at IARC 2016 about the volume of data produced by genomic sequencing on a personal and industrial level, and how to translate this into medically actionable information.

Druggable mutations are drivers behind many tumours, and Dr Eils details how determining the root of a patient's disease is revolutionising personalised cancer care.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation